Literature DB >> 2180828

Glucose homeostasis and endogenous opioid peptides.

K Ramabadran1, M Bansinath.   

Abstract

The primary objective of this review is to give an overview of the relationship between opioid peptides and glucose homeostasis. Although extensive work has been done regarding the role of endogenous opioid peptides, the existing evidences seem preliminary. The probability of endogenous opioid systems representing a part of an integrated system involving different neurotransmitters appears to be the basis for some of the discrepant data. Much research work remains to be done before a clear understanding of the physiological and/or pathophysiological role of endogenous opioids in glucose homeostasis could emerge.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180828

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  3 in total

1.  δ-Opioid receptors stimulate GLUT1-mediated glucose uptake through Src- and IGF-1 receptor-dependent activation of PI3-kinase signalling in CHO cells.

Authors:  Maria C Olianas; Simona Dedoni; Pierluigi Onali
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

2.  A history of opioid exposure in females increases the risk of metabolic disorders in their future male offspring.

Authors:  Anika M Toorie; Fair M Vassoler; Fangfang Qu; Christopher M Schonhoff; Steven Bradburn; Christopher A Murgatroyd; Donna K Slonim; Elizabeth M Byrnes
Journal:  Addict Biol       Date:  2019-11-28       Impact factor: 4.280

Review 3.  Potentials of Neuropeptides as Therapeutic Agents for Neurological Diseases.

Authors:  Xin Yi Yeo; Grace Cunliffe; Roger C Ho; Su Seong Lee; Sangyong Jung
Journal:  Biomedicines       Date:  2022-02-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.